Search Results - "Kuo, D. Y.S."

Characterization of the endometrial, cervicovaginal and anorectal microbiota in post-menopausal women with endometrioid and serous endometrial cancers by Gressel, Gregory M, Usyk, Mykhaylo, Frimer, Marina, Kuo, D Y S, Burk, Robert D

“…To characterize the microbiota of postmenopausal women undergoing hysterectomy for endometrioid (EAC) or uterine serous cancers (USC) compared to controls with…”
Get full text

Readability assessment of online gynecologic oncology patient education materials from major governmental, non-profit and pharmaceutical organizations by Samuel, David, Vilardo, Nicole, Isani, Sara S, Kuo, D.Y.S, Gressel, Gregory M

“…AbstractObjectivePatients are increasingly using online materials to learn about gynecologic cancer. Providers can refer patients to online educational…”
Get full text

Utilizing the Patient Reported Outcomes Measurement Information System (PROMIS®) to increase referral to ancillary support services for severely symptomatic patients with gynecologic cancer by Gressel, Gregory M., Dioun, Shayan M., Richley, Michael, Lounsbury, David W., Rapkin, Bruce D., Isani, Sara, Nevadunsky, Nicole S., Kuo, D.Y.S., Novetsky, Akiva P.

“…The Patient-Reported Outcomes Measurement Information System (PROMIS®) Network has developed a comprehensive repository of electronic patient reported outcomes…”
Get full text

Use of aromatase inhibitors in menopausal deep endometriosis: a case report and literature review by Rotenberg, O., Kuo, D. Y. S., Goldberg, G. L.

“…We report and review the clinical effectiveness of aromatase inhibitors in a patient with refractory, recurrent and infiltrating endometriosis. We demonstrate…”
Get full text

Abstract 5143: Characterization of the cervicovaginal, endometrial and anorectal microbiota and mycobiota of post-menopausal women with endometrioid and serous endometrial cancers by Gressel, Gregory M., Frimer, Marina, Zolnik, Christine P., Usyk, Mykhaylo, Miller, Devin T., Miller, Eirwen M., Kuo, D. Y.S., Burk, Robert D.

“…Objectives: Dysbiosis is thought to promote endothelial dysfunction and chronic inflammation, resulting in many chronic human diseases including cancer. This…”
Get full text

Low molecular weight serum cell-free DNA concentration is associated with clinicopathologic indices of poor prognosis in women with uterine cancer by Gressel, Gregory M, Maggi, Elaine C, Harmon, Bryan E, Ye, Kenny Q, Kuo, D Y S, Dolan, Siobhan M, Montagna, Cristina

“…Serum cell-free DNA (cfDNA) holds promise as a non-invasive cancer biomarker. The objective of this study was to evaluate the association of cfDNA…”
Get full text

The association of sexual dysfunction with race in women with gynecologic malignancies by Frimer, M., Turker, L.B., Shankar, V., Cardaci, R., Van Arsdale, A.R., Rosenthal, E., Kuo, D.Y.S., Goldberg, G.L., Nevadunsky, N.

“…Gynecologic cancer survivors report sexual health among their highest concerns. The aim of this study was to identify the prevalence of sexual dysfunction (SD)…”
Get full text

Novel neurosensory testing in cancer patients treated with the epothilone B analog, ixabepilone by Goel, S., Goldberg, G. L., Kuo, D. Y.-S., Muggia, F., Arezzo, J., Mani, S.

“…Background: We have previously established the recommended phase II dose (RPTD) of ixabepilone as 40 mg/m2 administered over 1 h repeated every 3 weeks with…”
Get full text